{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:01:04Z","timestamp":1761948064648},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,8,21]],"date-time":"2015-08-21T00:00:00Z","timestamp":1440115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00198-015-3246-3","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T08:39:23Z","timestamp":1440059963000},"page":"499-507","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Elevated incidence of fractures in women with invasive breast cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"B. J.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. J.","family":"Gradishar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"McKoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Godinez-Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. B.","family":"Helenowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Bunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. P.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Guise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,21]]},"reference":[{"issue":"17","key":"3246_CR1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","volume":"287","author":"KE Lasser","year":"2002","unstructured":"Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH (2002) Timing of new black box warnings and withdrawals for prescription medications. Jama 287(17):2215\u20132220","journal-title":"Jama"},{"key":"3246_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T et al (2004) Cancer statistics. CA Cancer J Clin 54:8\u201329","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"3246_CR3","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","volume":"19","author":"CL Shapiro","year":"2001","unstructured":"Shapiro CL, Manola J, Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19(14):3306\u20133311","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"4","key":"3246_CR4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","volume":"15","author":"T Saarto","year":"1997","unstructured":"Saarto T, Blomqvist C, Valimaki M, Makela P, Sarna S, Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 15(4):1341\u20131347","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"6","key":"3246_CR5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ctrv.2007.04.005","volume":"33","author":"H Ding","year":"2007","unstructured":"Ding H, Field TS (2007) Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen? Cancer Treat Rev 33(6):506\u2013513","journal-title":"Cancer Treat Rev"},{"issue":"32","key":"3246_CR6","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1200\/JCO.2007.15.7123","volume":"26","author":"AL Cooke","year":"2008","unstructured":"Cooke AL, Metge C, Lix L, Prior HJ, Leslie WD (2008) Tamoxifen use and osteoporotic fracture risk: a population-based analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(32):5227\u20135232","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"3246_CR7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","volume":"11","author":"TA Guise","year":"2006","unstructured":"Guise TA (2006) Bone loss and fracture risk associated with cancer therapy. Oncologist 11(10):1121\u20131131","journal-title":"Oncologist"},{"issue":"4","key":"3246_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/bjc.1996.73","volume":"73","author":"WR Miller","year":"1996","unstructured":"Miller WR (1996) Aromatase inhibitors\u2014where are we now? Br J Cancer 73(4):415\u2013417","journal-title":"Br J Cancer"},{"key":"3246_CR9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ejca.2005.10.028","volume":"42","author":"EV McCloskey","year":"2006","unstructured":"McCloskey EV (2006) Effects of third-generation aromatase inhibitors on bone. Eur J Cancer 42:1044\u20131051","journal-title":"Eur J Cancer"},{"issue":"9","key":"3246_CR10","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"M Baum","year":"2003","unstructured":"Baum M, Buzdar A, Cuzick J et al (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial efficacy and safety update analyses. Cancer 98(9):1802\u20131810","journal-title":"Cancer"},{"issue":"3","key":"3246_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/B:BREA.0000025420.78346.f9","volume":"85","author":"B Thurlimann","year":"2004","unstructured":"Thurlimann B, Hess D, Koberle D et al (2004) Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21\/95\u2014a sub-study of the TARGET (Tamoxifen or \u2018Arimidex\u2019 Randomized Group Efficacy and Tolerability) trial. Breast Cancer Res Treat 85(3):247\u2013254","journal-title":"Breast Cancer Res Treat"},{"key":"3246_CR12","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"B Thurlimann","year":"2005","unstructured":"Thurlimann B, Keshaviah A, Coates AS et al (2005) Breast International Group (BIG) 1\u201398 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747\u20132757","journal-title":"N Engl J Med"},{"issue":"3","key":"3246_CR13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-10-1595","volume":"17","author":"BJ Edwards","year":"2011","unstructured":"Edwards BJ, Raisch DW, Shankaran V et al (2011) Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 17(3):560\u2013568","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"3","key":"3246_CR14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","volume":"15","author":"PD Delmas","year":"1997","unstructured":"Delmas PD, Balena R, Confravreux E, Hardouin C, Hardy P, Bremond A (1997) Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 15(3):955\u2013962","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"7","key":"3246_CR15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S1470-2045(11)70151-6","volume":"12","author":"A Brufsky","year":"2011","unstructured":"Brufsky A (2011) Adjuvant bisphosphonates for early-stage breast cancer. Lancet Oncol 12(7):610\u2013611","journal-title":"Lancet Oncol"},{"issue":"7","key":"3246_CR16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1200\/JCO.2005.05.3744","volume":"25","author":"A Brufsky","year":"2007","unstructured":"Brufsky A, Harker WG, Beck JT et al (2007) Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(7):829\u2013836","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"Suppl 1","key":"3246_CR17","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.3816\/CBC.2007.s.004","volume":"7","author":"R Coleman","year":"2007","unstructured":"Coleman R (2007) Potential use of bisphosphonates in the prevention of metastases in early-stage breast cancer. Clin Breast Cancer 7(Suppl 1):S29\u2013S35","journal-title":"Clin Breast Cancer"},{"issue":"29","key":"3246_CR18","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1200\/JCO.2008.16.4707","volume":"26","author":"DL Hershman","year":"2008","unstructured":"Hershman DL, McMahon DJ, Crew KD et al (2008) Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(29):4739\u20134745","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"19","key":"3246_CR19","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1158\/1078-0432.CCR-07-5101","volume":"14","author":"JE Lester","year":"2008","unstructured":"Lester JE, Dodwell D, Purohit OP et al (2008) Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 14(19):6336\u20136342","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"30","key":"3246_CR20","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1200\/JCO.2008.16.3832","volume":"26","author":"GK Ellis","year":"2008","unstructured":"Ellis GK, Bone HG, Chlebowski R et al (2008) Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(30):4875\u20134882","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"28","key":"3246_CR21","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","volume":"25","author":"A Lipton","year":"2007","unstructured":"Lipton A, Steger GG, Figueroa J et al (2007) Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 25(28):4431\u20134437","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"3246_CR22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0076","volume":"7","author":"JR Gralow","year":"2009","unstructured":"Gralow JR, Biermann JS, Farooki A et al (2009) NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw 7(3):S1\u2013S32, quiz S33-35","journal-title":"J Natl Compr Canc Netw"},{"issue":"9453","key":"3246_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer. Lancet 365(9453):60\u201362","journal-title":"Lancet"},{"issue":"1","key":"3246_CR24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"SC Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam study. Bone 34(1):195\u2013202","journal-title":"Bone"},{"key":"3246_CR25","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/jc.2004-1568","volume":"90","author":"SA Wainwright","year":"2005","unstructured":"Wainwright SA, Marshall LM, Ensrud K et al (2005) Hip fracture in women without osteoporosis. J Clin Endocr Metab 90:2787\u20132793","journal-title":"J Clin Endocr Metab"},{"issue":"17","key":"3246_CR26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.1996.03540170048031","volume":"276","author":"JA Cauley","year":"1996","unstructured":"Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR (1996) Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. Jama 276(17):1404\u20131408","journal-title":"Jama"},{"issue":"3","key":"3246_CR27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.maturitas.2006.09.005","volume":"56","author":"P Hadji","year":"2007","unstructured":"Hadji P, Gottschalk M, Ziller V, Kalder M, Jackisch C, Wagner U (2007) Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT). Maturitas 56(3):312\u2013321","journal-title":"Maturitas"},{"issue":"9","key":"3246_CR28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM199702273360903","volume":"336","author":"Y Zhang","year":"1997","unstructured":"Zhang Y, Kiel DP, Kreger BE et al (1997) Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336(9):611\u2013617","journal-title":"N Engl J Med"},{"issue":"12","key":"3246_CR29","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","volume":"90","author":"S Boutroy","year":"2005","unstructured":"Boutroy S, Bouxsein ML, Munoz F, Delmas PD (2005) In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 90(12):6508\u20136515","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"3246_CR30","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","volume":"95","author":"AJ Burghardt","year":"2010","unstructured":"Burghardt AJ, Issever AS, Schwartz AV et al (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(11):5045\u20135055","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3246_CR31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","volume":"84","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2009) Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 84(1):45\u201355","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"3246_CR32","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1359\/jbmr.2000.15.7.1368","volume":"15","author":"A Oleksik","year":"2000","unstructured":"Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 15(7):1368\u20131375","journal-title":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research"},{"issue":"11","key":"3246_CR33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thx.46.11.803","volume":"46","author":"M Luengo","year":"1991","unstructured":"Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J (1991) Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 46(11):803\u2013806","journal-title":"Thorax"},{"issue":"2","key":"3246_CR34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S8756-3282(01)00673-1","volume":"30","author":"XE Guo","year":"2002","unstructured":"Guo XE, Kim CH (2002) Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone 30(2):404\u2013411","journal-title":"Bone"},{"key":"3246_CR35","doi-asserted-by":"crossref","unstructured":"Cheung AM, Robbins J, Pruthi S, et al. Cortical porosity and estimated bone strength in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: Analyses from the nested bone strength substudy of the map.3 trial (MAP3BSS). Journal of Bone and Mineral Research. 2012;27.","DOI":"10.1016\/S1470-2045(11)70389-8"},{"key":"3246_CR36","first-page":"S289","volume":"23","author":"P Hadji","year":"2012","unstructured":"Hadji P, Kalder M, Kauka A, Bauer M, Ziller M, Hans D (2012) Effects of exemestane and tamoxifen treatments on bone quantity and quality in patient with breast cancer. Osteoporos Int 23:S289\u2013S290","journal-title":"Osteoporos Int"},{"key":"3246_CR37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1158\/1538-7445.AM2012-6","volume":"72","author":"T Shao","year":"2012","unstructured":"Shao T, Shane ES, McMahon D et al (2012) Effects of high dose of bisphosphonate therapy on bone microarchitecture of the peripheral skeleton in women with early stage breast cancer. Cancer Res 72:6\u201312, 03","journal-title":"Cancer Res"},{"issue":"7","key":"3246_CR38","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1210\/jc.2011-0309","volume":"96","author":"EM Stein","year":"2011","unstructured":"Stein EM, Liu XS, Nickolas TL et al (2011) Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab 96(7):2041\u20132048","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3246_CR39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jclinepi.2010.07.007","volume":"64","author":"AH Warriner","year":"2011","unstructured":"Warriner AH, Patkar NM, Curtis JR et al (2011) Which fractures are most attributable to osteoporosis? J Clin Epidemiol 64(1):46\u201353","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"3246_CR40","doi-asserted-by":"crossref","first-page":"M862","DOI":"10.1093\/gerona\/58.9.M862","volume":"58","author":"T Liu-Ambrose","year":"2003","unstructured":"Liu-Ambrose T, Eng JJ, Khan KM, Carter ND, McKay HA (2003) Older women with osteoporosis have increased postural sway and weaker quadriceps strength than counterparts with normal bone mass: overlooked determinants of fracture risk? J Gerontol A Biol Sci Med Sci 58(9):M862\u2013M866","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"14","key":"3246_CR41","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.jbiomech.2010.06.017","volume":"43","author":"JD Wernle","year":"2010","unstructured":"Wernle JD, Damron TA, Allen MJ, Mann KA (2010) Local irradiation alters bone morphology and increases bone fragility in a mouse model. J Biomech 43(14):2738\u20132746","journal-title":"J Biomech"},{"issue":"Suppl 2","key":"3246_CR42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00198-004-1702-6","volume":"16","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 16(Suppl 2):S3\u2013S7","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"1","key":"3246_CR43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01623439","volume":"4","author":"SR Cummings","year":"1994","unstructured":"Cummings SR, Nevitt MC (1994) Non-skeletal determinants of fractures: the potential importance of the mechanics of falls. Study of Osteoporotic Fractures Research Group. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 4(1):67\u201370","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"3246_CR44","doi-asserted-by":"crossref","unstructured":"Body JJ, Bergmann P, Boonen S, et al. Management of cancer treatment-induced bone loss in early breast and prostate cancer\u2014a consensus paper of the Belgian Bone Club Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2007;epub.","DOI":"10.1007\/s00198-007-0439-4"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-015-3246-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-015-3246-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T12:42:31Z","timestamp":1567082551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-015-3246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,21]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3246"],"URL":"https:\/\/doi.org\/10.1007\/s00198-015-3246-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,21]]}}}